Brochure
12 May 2021

Impact of a Pandemic Outbreak on Vaccine Development Approach

PDF 1.3 MB

Over the past decade, outbreaks of H1N1 influenza, Sars-Cov, Ebola, and MERS have triggered several discussions about traditional vaccine development methods1. For example, new platform technologies, such as the use of messenger RNA (mRNA) vehiculated through lipid nanoparticles, have been introduced, stimulating scientific discussions. With the spread of SARS-CoV-2 intensifying, scientists, together with pharmaceutical companies, are reinventing the approach of how to bring these life-saving drugs to market faster without impacting product quality, safety, or efficacy.

Content provided by our supplier

Thermo Fisher Scientific Inc.

  • US
  • 2015
    On CPhI since
  • 5000+
    Employees

Other Content from Thermo Fisher Scientific Inc.